{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:25:14Z","timestamp":1791401114867,"version":"4.3.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Deep brain stimulation (DBS) is an efficient treatment for movement disorders, most commonly Parkinson\u2019s Disease (PD), dystonia and essential tremor. DBS surgery carries risks, e.g. the risk of delayed peri-lead edema (PLE) and the risk of postoperative cognitive decline. The mechanisms of these complications are not fully understood and there is no established biomarker to screen for these complications after DBS surgery. To explore the diagnostic value of two blood-based markers representative for distinct types of brain injury, we characterized the dynamics of serum glial fibrillary acidic protein (sGFAP, for glial injury) and serum neurofilament light chain (sNfL, for neuronal-axonal injury) following DBS surgery. We analyzed longitudinal dynamics of serum protein levels in 58 patients undergoing deep brain stimulation (DBS) at our center for half a year post-surgery. Serum GFAP responded much more rapidly after brain surgery, returning to baseline after weeks, whereas sNfL only returned to baseline after months. Patients with lower preoperative cognitive performance exhibited higher postoperative sGFAP levels, with sGFAP showing a stronger association with preoperative patient characteristics compared to sNfL. Further studies with long-term clinical follow-up are needed to fully evaluate the utility of sGFAP as a biomarker for both early and delayed complications after DBS surgery, including cognitive decline and potential foreign body reactions to the implanted lead.<\/jats:p>","DOI":"10.1038\/s41598-025-00399-3","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T02:30:43Z","timestamp":1747103443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum glial fibrillary protein reflects early brain injury dynamics and cognitive changes after deep brain stimulation surgery"],"prefix":"10.1038","volume":"15","author":[{"given":"Anika","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Arjomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bendig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Delfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Klingelhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold H.","family":"Polanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalf","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Falkenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schnalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"399_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41582-019-0145-9","volume":"15","author":"P Limousin","year":"2019","unstructured":"Limousin, P. & Foltynie, T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat. Rev. Neurol. 15, 234\u2013242 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"399_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/mds.23195","volume":"25","author":"ED Flora","year":"2010","unstructured":"Flora, E. D., Perera, C. L., Cameron, A. L. & Maddern, G. J. Deep brain stimulation for essential tremor: A systematic review. Mov. Disord. Off. J. Mov. Disord. Soc. 25, 1550\u20131559 (2010).","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"399_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(14)70143-7","volume":"13","author":"J Volkmann","year":"2014","unstructured":"Volkmann, J. et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: A randomised, sham-controlled trial. Lancet Neurol. 13, 875\u2013884 (2014).","journal-title":"Lancet Neurol."},{"key":"399_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.630391","volume":"11","author":"S Tisch","year":"2021","unstructured":"Tisch, S. & Kumar, K. R. Pallidal deep brain stimulation for monogenic dystonia: The effect of gene on outcome. Front. Neurol. 11, 630391 (2021).","journal-title":"Front. Neurol."},{"key":"399_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mdc3.13161","volume":"8","author":"P Azevedo","year":"2021","unstructured":"Azevedo, P., Aquino, C. C. & Fasano, A. Surgical management of Parkinson\u2019s disease in the elderly. Mov. Disord. Clin. Pract. 8, 500\u2013509 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"399_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2024.1319520","author":"J Al Ali","year":"2024","unstructured":"Al Ali, J. et al. Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: A systematic review. Front. Hum. Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2024.1319520 (2024).","journal-title":"Front. Hum. Neurosci."},{"key":"399_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00066","author":"J Massano","year":"2012","unstructured":"Massano, J. & Garrett, C. Deep brain stimulation and cognitive decline in Parkinson\u2019s disease: A clinical review. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2012.00066 (2012).","journal-title":"Front. Neurol."},{"key":"399_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3171\/2023.11.JNS232164","volume":"141","author":"JW Chen","year":"2024","unstructured":"Chen, J. W. et al. Electrode position and cognitive outcome following deep brain stimulation surgery. J. Neurosurg. 141, 230\u2013240 (2024).","journal-title":"J. Neurosurg."},{"key":"399_CR9","doi-asserted-by":"publisher","first-page":"1258190","DOI":"10.3389\/fnagi.2023.1258190","volume":"15","author":"MC Olson","year":"2023","unstructured":"Olson, M. C., Shill, H., Ponce, F. & Aslam, S. Deep brain stimulation in PD: Risk of complications, morbidity, and hospitalizations: a systematic review. Front. Aging Neurosci. 15, 1258190 (2023).","journal-title":"Front. Aging Neurosci."},{"issue":"Suppl 14","key":"399_CR10","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1002\/mds.20962","volume":"21","author":"G Kleiner-Fisman","year":"2006","unstructured":"Kleiner-Fisman, G. et al. Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes. Mov. Disord. Off. J. Mov. Disord. Soc. 21(Suppl 14), S290-304 (2006).","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"399_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.867055","author":"V Ra\u010dki","year":"2022","unstructured":"Ra\u010dki, V. et al. Cognitive impact of deep brain stimulation in Parkinson\u2019s disease patients: A systematic review. Front. Hum. Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2022.867055 (2022).","journal-title":"Front. Hum. Neurosci."},{"key":"399_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.25994","volume":"89","author":"F Cavallieri","year":"2021","unstructured":"Cavallieri, F. et al. Predictors of long-term outcome of subthalamic stimulation in Parkinson disease. Ann. Neurol. 89, 587\u2013597 (2021).","journal-title":"Ann. Neurol."},{"key":"399_CR13","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/mds.29647","volume":"38","author":"GD Pal","year":"2023","unstructured":"Pal, G. D. et al. Cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease with GBA1 pathogenic variants. Mov. Disord. 38, 2155\u20132162 (2023).","journal-title":"Mov. Disord."},{"key":"399_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/mds.23770","volume":"26","author":"J Kimmelman","year":"2011","unstructured":"Kimmelman, J. et al. Risk of surgical delivery to deep nuclei: A meta-analysis. Mov. Disord. Off. J. Mov. Disord. Soc. 26, 1415\u20131421 (2011).","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"399_CR15","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/j.wneu.2018.12.092","volume":"124","author":"AC Whiting","year":"2019","unstructured":"Whiting, A. C. et al. Peri-lead edema after deep brain stimulation surgery: A poorly understood but frequent complication. World Neurosurg. 124, e340\u2013e345 (2019).","journal-title":"World Neurosurg."},{"key":"399_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e08900","volume":"8","author":"Y Nishiguchi","year":"2022","unstructured":"Nishiguchi, Y. et al. Relationship of brain edema after deep brain stimulation surgery with motor and cognitive function. Heliyon 8, e08900 (2022).","journal-title":"Heliyon"},{"key":"399_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.parkreldis.2016.09.007","volume":"32","author":"CMKE de Cuba","year":"2016","unstructured":"de Cuba, C. M. K. E. et al. Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review. Parkinsonism Relat. Disord. 32, 108\u2013115 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"399_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.740939","volume":"12","author":"RG Mira","year":"2021","unstructured":"Mira, R. G., Lira, M. & Cerpa, W. Traumatic brain injury: Mechanisms of glial response. Front. Physiol. 12, 740939 (2021).","journal-title":"Front. Physiol."},{"key":"399_CR19","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41598-022-05117-x","volume":"12","author":"A Frank","year":"2022","unstructured":"Frank, A. et al. Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not. Sci. Rep. 12, 1446 (2022).","journal-title":"Sci. Rep."},{"key":"399_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak, A. et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat. Rev. Neurol. 18, 158\u2013172 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"399_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","volume":"258","author":"M Axelsson","year":"2011","unstructured":"Axelsson, M. et al. Glial fibrillary acidic protein: A potential biomarker for progression in multiple sclerosis. J. Neurol. 258, 882\u2013888 (2011).","journal-title":"J. Neurol."},{"key":"399_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","volume":"80","author":"S Meier","year":"2023","unstructured":"Meier, S. et al. Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis. JAMA Neurol. 80, 287\u2013297 (2023).","journal-title":"JAMA Neurol."},{"key":"399_CR23","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","volume":"271","author":"A Pilotto","year":"2024","unstructured":"Pilotto, A. et al. Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson\u2019s disease. J. Neurol. 271, 7537\u20137546 (2024).","journal-title":"J. Neurol."},{"key":"399_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00430-8","volume":"9","author":"Y Tang","year":"2023","unstructured":"Tang, Y. et al. Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. Npj Park. Dis. 9, 1\u20135 (2023).","journal-title":"Npj Park. Dis."},{"key":"399_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-024-00664-8","volume":"10","author":"N Che","year":"2024","unstructured":"Che, N. et al. Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease. Npj Park. Dis. 10, 48 (2024).","journal-title":"Npj Park. Dis."},{"key":"399_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148660","volume":"1822","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson\u2019s disease. Brain Res. 1822, 148660 (2024).","journal-title":"Brain Res."},{"key":"399_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.779890","author":"H You","year":"2021","unstructured":"You, H. et al. Evaluation of blood glial fibrillary acidic protein as a potential marker in Huntington\u2019s disease. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.779890 (2021).","journal-title":"Front. Neurol."},{"key":"399_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3171\/2022.5.JNS22638","volume":"138","author":"AM Casta\u00f1o-Leon","year":"2022","unstructured":"Casta\u00f1o-Leon, A. M. et al. Serum assessment of traumatic axonal injury: The correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility. J. Neurosurg. 138, 454\u2013464 (2022).","journal-title":"J. Neurosurg."},{"key":"399_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0271678X231172520","volume":"43","author":"F Ferrari","year":"2023","unstructured":"Ferrari, F. et al. Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients. J. Cereb. Blood Flow Metab. 43, 1601\u20131611 (2023).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"399_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200045","volume":"10","author":"Y Yalachkov","year":"2023","unstructured":"Yalachkov, Y. et al. Effect of estimated blood volume and body mass index on GFAP and NfL levels in the serum and CSF of patients with multiple sclerosis. Neurol. Neuroimmunol. Neuroinflam. 10, e200045 (2023).","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"399_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang, X., Shi, Z., Qiu, Y., Sun, D. & Zhou, H. Peripheral GFAP and NfL as early biomarkers for dementia: Longitudinal insights from the UK Biobank. BMC Med. 22, 192 (2024).","journal-title":"BMC Med."},{"key":"399_CR32","first-page":"1117","volume":"11","author":"L-Z Ma","year":"2021","unstructured":"Ma, L.-Z. et al. Serum neurofilament dynamics predicts cognitive progression in de novo Parkinson\u2019s disease. J. Park. Dis. 11, 1117\u20131127 (2021).","journal-title":"J. Park. Dis."},{"key":"399_CR33","doi-asserted-by":"publisher","first-page":"6612871","DOI":"10.1155\/2020\/6612871","volume":"2020","author":"W Ma","year":"2020","unstructured":"Ma, W. et al. Elevated levels of serum neurofilament light chain associated with cognitive impairment in vascular dementia. Dis. Markers 2020, 6612871 (2020).","journal-title":"Dis. Markers"},{"key":"399_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.668606","volume":"12","author":"S Azizi","year":"2021","unstructured":"Azizi, S. et al. A kinetic model for blood biomarker levels after mild traumatic brain injury. Front. Neurol. 12, 668606 (2021).","journal-title":"Front. Neurol."},{"key":"399_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil, M. et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat. Commun. 11, 812 (2020).","journal-title":"Nat. Commun."},{"key":"399_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/acn3.50972","volume":"7","author":"A Manouchehrinia","year":"2020","unstructured":"Manouchehrinia, A. et al. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann. Clin. Transl. Neurol. 7, 139\u2013143 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"399_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-023-00605-x","volume":"10","author":"A Frank","year":"2024","unstructured":"Frank, A. et al. Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson\u2019s disease. Npj Park. Dis. 10, 14 (2024).","journal-title":"Npj Park. Dis."},{"key":"399_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/mdc3.13698","volume":"10","author":"N Schnalke","year":"2023","unstructured":"Schnalke, N. et al. Morbidity milestones demonstrate long disability-free survival in Parkinson\u2019s disease patients with deep brain stimulation of the subthalamic nucleus. Mov. Disord. Clin. Pract. 10, 569\u2013578 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"399_CR39","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster, P. A., O\u2019Sullivan, S. S., Holton, J. L., Revesz, T. & Lees, A. J. Relationships between age and late progression of Parkinson\u2019s disease: A clinico-pathological study. Brain 133, 1755\u20131762 (2010).","journal-title":"Brain"},{"key":"399_CR40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/ene.13852","volume":"26","author":"L Borellini","year":"2019","unstructured":"Borellini, L. et al. Peri-lead edema after deep brain stimulation surgery for Parkinson\u2019s disease: A prospective magnetic resonance imaging study. Eur. J. Neurol. 26, 533\u2013539 (2019).","journal-title":"Eur. J. Neurol."},{"key":"399_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/glia.23734","volume":"68","author":"D Li","year":"2020","unstructured":"Li, D. et al. Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes. Glia 68, 878\u2013897 (2020).","journal-title":"Glia"},{"key":"399_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/brain\/awad322","volume":"147","author":"A Kouli","year":"2023","unstructured":"Kouli, A. et al. Neuroinflammation is linked to dementia risk in Parkinson\u2019s disease. Brain 147, 923\u2013935 (2023).","journal-title":"Brain"},{"key":"399_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","volume":"14","author":"G-L Defer","year":"1999","unstructured":"Defer, G.-L., Widner, H., Mari\u00e9, R.-M., R\u00e9my, P. & Levivier, M. Core assessment program for surgical interventional therapies in Parkinson\u2019s disease (CAPSIT-PD). Mov. Disord. 14, 572\u2013584 (1999).","journal-title":"Mov. Disord."},{"key":"399_CR44","first-page":"4328371","volume":"2018","author":"JA Foley","year":"2018","unstructured":"Foley, J. A., Foltynie, T., Limousin, P. & Cipolotti, L. Standardised neuropsychological assessment for the selection of patients undergoing DBS for Parkinson\u2019s disease. Park. Dis. 2018, 4328371 (2018).","journal-title":"Park. Dis."},{"key":"399_CR45","doi-asserted-by":"publisher","first-page":"eabg9922","DOI":"10.1126\/scitranslmed.abg9922","volume":"13","author":"NSN Graham","year":"2021","unstructured":"Graham, N. S. N. et al. Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci. Transl. Med. 13, eabg9922 (2021).","journal-title":"Sci. Transl. Med."},{"key":"399_CR46","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","volume":"95","author":"P Shahim","year":"2020","unstructured":"Shahim, P. et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology 95, e610\u2013e622 (2020).","journal-title":"Neurology"},{"key":"399_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.metip.2023.100120","volume":"8","author":"MA Garc\u00eda-P\u00e9rez","year":"2023","unstructured":"Garc\u00eda-P\u00e9rez, M. A. Use and misuse of corrections for multiple testing. Methods Psychol. 8, 100120 (2023).","journal-title":"Methods Psychol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00399-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T03:04:35Z","timestamp":1747105475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00399-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00399-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4968505\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16537"}}